The giant is paying $3.5 billion to cost Carson Block and others $58 million.
The post Short Seller Fails To Convince Novartis That Other Pharma Is Full Of It About Kidney Drug appeared first on Above the Law.
from Above the Law https://ift.tt/0aPnQ6v
via IFTTT